Key Highlights: Implications: The slump sale of Gennova’s small mRNA unit to Immunoscript for ₹139.5 crore effectively exits Emcure from a non-core, low-contribution bu...
Key Highlights: Implications: By reducing injections from 365 to 52 per year at near price parity, and potentially 20–25% lower annual treatment costs versus some analogue basals,&nbs...
Alkem Laboratories Limited is one of India’s leading pharmaceutical companies engaged in the development, manufacturing, and commercialization of branded generics, generic medicines, nutraceutic...
Syngene International Limited is one of Asia’s leading contract research, development, and manufacturing organizations (CRDMO), providing integrated scientific services to global pharmaceutical,...
Key Highlights: Implications: Mankind Pharma’s AI-led drug discovery partnership with Denovo Sciences strengthens its innovation agenda and adds another serious player to India’s eme...
Key Highlights: Implications: Pivot Path’s majority sale to an Ascent-led consortium effectively spins it out as an independent, PE-backed specialist, which should accelerate its growth in...
Ipca Laboratories Limited is a leading Indian pharmaceutical company engaged in the manufacturing and marketing of active pharmaceutical ingredients (APIs), branded formulations, and generic medicines...
Piramal Pharma Limited is a diversified global pharmaceutical company offering contract development and manufacturing services (CDMO), complex hospital generics, and consumer healthcare products. Form...